Stockscreener 앱 받기
14.02
0.50%
0.02
Mink Therapeutics Inc 주식(INKT)의 최신 뉴스
How to monitor MiNK Therapeutics Inc. with trend dashboardsInflation Watch & Real-Time Chart Pattern Alerts - newser.com
Price momentum metrics for MiNK Therapeutics Inc. explainedTrade Entry Summary & Fast Gain Stock Trading Tips - newser.com
Why MiNK Therapeutics Inc. stock could see breakout soon2025 Geopolitical Influence & Stepwise Swing Trade Plans - newser.com
MiNK Therapeutics Inc. stock trend forecast2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Why MiNK Therapeutics Inc. stock is popular among millennials2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Chart based analysis of MiNK Therapeutics Inc. trendsJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
MiNK Therapeutics Inc.’s volatility index tracking explainedWeekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com
Best data tools to analyze MiNK Therapeutics Inc. stockJuly 2025 Setups & Low Risk Profit Maximizing Plans - newser.com
Reversal indicators forming on MiNK Therapeutics Inc. stockJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for MiNK Therapeutics (NASDAQ:INKT) - MarketBeat
MiNK Therapeutics (NASDAQ:INKT) Stock Price Down 2.1% – Here’s Why - Defense World
Will MiNK Therapeutics Inc. (6Q40) stock see insider accumulationJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com
How to escape a deep drawdown in MiNK Therapeutics Inc.Fed Meeting & Real-Time Sentiment Analysis - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock undervalued historicallyAnalyst Upgrade & Weekly Return Optimization Plans - newser.com
Tools to assess MiNK Therapeutics Inc.’s risk profileJuly 2025 Summary & Free Daily Entry Point Trade Alerts - newser.com
MiNK Therapeutics Inc. stock prediction for this weekQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
Evaluating MiNK Therapeutics Inc. with trendline analysisQuarterly Earnings Summary & High Yield Stock Recommendations - newser.com
How MiNK Therapeutics Inc. (6Q40) stock moves in volatile trading sessions2025 Top Decliners & Free Low Drawdown Momentum Trade Ideas - newser.com
Risk vs reward if holding onto MiNK Therapeutics Inc.2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
What analysts say about MiNK Therapeutics Inc stockFundamental Stock Analysis & Fast Profit Portfolio Plans - earlytimes.in
Published on: 2025-10-03 05:09:10 - earlytimes.in
LakeShore Biopharma (NASDAQ:LSB) & MiNK Therapeutics (NASDAQ:INKT) Financial Survey - Defense World
MiNK Therapeutics appoints trauma expert Dr. John Holcomb to board By Investing.com - Investing.com Nigeria
What analysts say about MiNK Therapeutics Inc 6Q40 stockQuarterly Earnings Review & Free Discover Massive Upside Stocks - earlytimes.in
MiNK Therapeutics appoints trauma expert Dr. John Holcomb to board - Investing.com
MiNK Therapeutics Appoints Colonel (Ret.) John B. Holcomb, MD, FACS to Board of Directors - Quiver Quantitative
MiNK Therapeutics appoints Colonel (Ret.) John B. Holcomb to board of directors - MarketScreener
MiNK Therapeutics Appoints Colonel (Ret.) John B. Holcomb, MD, to Board of Directors - GlobeNewswire
Military Medicine Legend with 780 Publications: MiNK Therapeutics Adds Combat Care Pioneer to Board - Stock Titan
1.22%
자본화:
|
볼륨(24시간):